While it's pretty common knowledge that different people have different blood types, that information might actually mean a ...

The instinct to protect and secure a child’s future—especially when it comes to their health—is one of the deepest and most ...

Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who ...

EXCLUSIVE: Two brothers were shocked when diagnosed with prostate cancer within a month of each other. But luckily that ...

Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

A study shows that ctDNA tests can detect tumours up to three years before before traditional testing methods would have ...

T-bet is a transcription factor, one of the control proteins in the cell nucleus that can turn specific groups of genes on ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...